Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BIB NASDAQ:HEAL NASDAQ:IBBQ NASDAQ:MEDX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIBProShares Ultra Nasdaq Biotechnology$51.01+1.0%$47.72$33.78▼$69.17$51.52M1.639,433 shs8,001 shsHEALGlobal X HealthTech ETF$10.32-1.0%$10.58$8.16▼$11.91$43.24M1.0925,403 shs27,865 shsIBBQInvesco Nasdaq Biotechnology ETF$22.40+0.6%$21.55$17.84▼$24.84$34.05M0.6113,000 shs23,900 shsMEDXHorizon Kinetics Medical ETF$27.72+1.2%$27.07$23.46▼$32.00$16.35M0.911,837 shs1,124 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIBProShares Ultra Nasdaq Biotechnology0.00%-2.93%+5.52%+8.74%-19.78%HEALGlobal X HealthTech ETF0.00%-2.82%-2.92%+1.98%+1,031,999,900.00%IBBQInvesco Nasdaq Biotechnology ETF0.00%-1.45%+3.15%+6.11%-5.21%MEDXHorizon Kinetics Medical ETF0.00%-0.83%+1.05%+3.82%-9.46%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBIBProShares Ultra Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AN/AN/AHEALGlobal X HealthTech ETFN/AN/AN/AN/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBIBProShares Ultra Nasdaq Biotechnology 2.65Moderate Buy$51.01N/AHEALGlobal X HealthTech ETF 2.64Moderate Buy$10.32N/AIBBQInvesco Nasdaq Biotechnology ETF 2.66Moderate Buy$22.40N/AMEDXHorizon Kinetics Medical ETF 2.65Moderate Buy$27.72N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBIBProShares Ultra Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AHEALGlobal X HealthTech ETFN/AN/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBIBProShares Ultra Nasdaq BiotechnologyN/AN/A20.68∞N/AN/AN/AN/AN/AHEALGlobal X HealthTech ETFN/AN/A42.80∞N/AN/AN/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/AN/A17.03∞N/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/A19.02∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBIBProShares Ultra Nasdaq Biotechnology$0.851.67%N/AN/AN/AHEALGlobal X HealthTech ETFN/A0.08%N/AN/AN/AIBBQInvesco Nasdaq Biotechnology ETF$0.220.98%N/AN/AN/AMEDXHorizon Kinetics Medical ETF$0.501.80%N/AN/AN/ALatest IBBQ, HEAL, MEDX, and BIB DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/26/2025HEALGlobal X HealthTech ETF$0.00826/27/20256/27/20257/7/20256/24/2025BIBProShares Ultra Nasdaq BiotechnologyQuarterly$0.17061.49%6/25/20256/25/20257/1/20256/23/2025IBBQInvesco Nasdaq Biotechnology ETFQuarterly$0.02870.55%6/23/20256/23/20256/27/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBIBProShares Ultra Nasdaq BiotechnologyN/AHEALGlobal X HealthTech ETFN/AIBBQInvesco Nasdaq Biotechnology ETFN/AMEDXHorizon Kinetics Medical ETF62.18%Insider OwnershipCompanyInsider OwnershipBIBProShares Ultra Nasdaq BiotechnologyN/AHEALGlobal X HealthTech ETFN/AIBBQInvesco Nasdaq Biotechnology ETFN/AMEDXHorizon Kinetics Medical ETF4.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBIBProShares Ultra Nasdaq BiotechnologyN/A1.01 millionN/AOptionableHEALGlobal X HealthTech ETFN/A4.19 millionN/AN/AIBBQInvesco Nasdaq Biotechnology ETFN/A1.52 millionN/AOptionableMEDXHorizon Kinetics Medical ETFN/A590,000N/ANot OptionableIBBQ, HEAL, MEDX, and BIB HeadlinesRecent News About These CompaniesHorizon Kinetics Holding Corporation Reports First Quarter ResultsMay 14, 2025 | accessnewswire.comAHorizon Kinetics Holding Corporation Reports Fourth Quarter and Annual ResultsMarch 26, 2025 | accessnewswire.comAETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts OutlookMay 1, 2024 | zacks.comHorizon Kinetics ISE Wealth (RCH)May 13, 2023 | uk.investing.comHORIZON Fushi ChinaA 50 ETF (512150)May 11, 2023 | investing.comHorizon Kinetics Launches the Horizon Kinetics SPAC Active ETF (SPAQ) and the Horizon Kinetics Medical ETF (MEDX)April 19, 2023 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesRocket Lab: A Parabolic Run Meets a Healthy PullbackBy Ryan Hasson | July 23, 2025View Rocket Lab: A Parabolic Run Meets a Healthy PullbackForget the Weak Dollar—These 3 Travel Stocks Are Still Taking OffBy Chris Markoch | July 6, 2025View Forget the Weak Dollar—These 3 Travel Stocks Are Still Taking OffDo They Know Something? Insiders & Congress Buy UnitedHealthBy Brian O'Connell | July 9, 2025View Do They Know Something? Insiders & Congress Buy UnitedHealthInsiders Spent Millions on These 3 Stocks Over the Past 2 MonthsBy Leo Miller | July 17, 2025View Insiders Spent Millions on These 3 Stocks Over the Past 2 MonthsHealthcare Stocks Hit Valuation Bottom, 3 Names to ReboundBy Gabriel Osorio-Mazilli | July 23, 2025View Healthcare Stocks Hit Valuation Bottom, 3 Names to ReboundIBBQ, HEAL, MEDX, and BIB Company DescriptionsProShares Ultra Nasdaq Biotechnology NASDAQ:BIB$51.01 +0.53 (+1.05%) Closing price 08/1/2025 03:58 PM EasternExtended Trading$50.97 -0.04 (-0.08%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.Global X HealthTech ETF NASDAQ:HEAL$10.32 -0.10 (-0.96%) As of 08/1/2025 03:56 PM EasternAn ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.Invesco Nasdaq Biotechnology ETF NASDAQ:IBBQ$22.40 +0.13 (+0.58%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$22.39 -0.01 (-0.04%) As of 08/1/2025 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.Horizon Kinetics Medical ETF NASDAQ:MEDX$27.72 +0.34 (+1.24%) Closing price 08/1/2025 02:35 PM EasternExtended Trading$27.72 +0.00 (+0.00%) As of 08/1/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund that mostly invests in health care equity. The fund actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments. MEDX was launched on Jan 27, 2023 and is managed by Horizon Kinetics. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale Is PG&E an AI Power Play? Why Options Traders Are Betting Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
